Previous Article | Next Article 
Journal of Virology, November 2002, p. 11133-11138, Vol. 76, No. 21
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.21.11133-11138.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Implication of the Lymphocyte-Specific Nuclear Body Protein Sp140 in an Innate Response to Human Immunodeficiency Virus Type 1
Navid Madani,1,
Robert Millette,1 Emily J. Platt,1 Mariana Marin,1 Susan L. Kozak,1 Donald B. Bloch,2 and David Kabat1*
Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon 97201-3098,1
Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts 021292
Received 5 April 2002/
Accepted 18 July 2002
The viral infectivity factor (Vif) of human immunodeficiency virus type 1 (HIV-1) neutralizes an unidentified antiviral pathway that occurs only in nonpermissive (NP) cells. Using a yeast two-hybrid screen of a human lymphocyte cDNA library, we identified several potential Vif partners. One, the nuclear body protein Sp140, was found specifically in all NP cells (n = 12 cell lines tested; P
0.001), and HIV-1 infection induced its partial dispersal from nuclear bodies into cytosolic colocalization with Vif. Our results implicate Sp140 in a response to HIV-1 that may be related to or coordinated with the pathway that inactivates HIV-1 lacking vif.
* Corresponding author. Mailing address: Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, OR 97201-3098. Phone: (503) 494-8442. Fax: (503) 494-8393. E-mail:
kabat{at}ohsu.edu.
Present address: Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
Journal of Virology, November 2002, p. 11133-11138, Vol. 76, No. 21
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.21.11133-11138.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.-C., Marquet, R.
(2009). Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol. Mol. Biol. Rev.
73: 211-232
[Abstract]
[Full Text]
-
Dang, Y., Siew, L. M., Zheng, Y.-H.
(2008). APOBEC3G Is Degraded by the Proteasomal Pathway in a Vif-dependent Manner without Being Polyubiquitylated. J. Biol. Chem.
283: 13124-13131
[Abstract]
[Full Text]
-
Wichroski, M. J., Ichiyama, K., Rana, T. M.
(2005). Analysis of HIV-1 Viral Infectivity Factor-mediated Proteasome-dependent Depletion of APOBEC3G: CORRELATING FUNCTION AND SUBCELLULAR LOCALIZATION. J. Biol. Chem.
280: 8387-8396
[Abstract]
[Full Text]
-
Feng, F., Davis, A., Lake, J.-A., Carr, J., Xia, W., Burrell, C., Li, P.
(2004). Ring Finger Protein ZIN Interacts with Human Immunodeficiency Virus Type 1 Vif. J. Virol.
78: 10574-10581
[Abstract]
[Full Text]
-
Kao, S., Khan, M. A., Miyagi, E., Plishka, R., Buckler-White, A., Strebel, K.
(2003). The Human Immunodeficiency Virus Type 1 Vif Protein Reduces Intracellular Expression and Inhibits Packaging of APOBEC3G (CEM15), a Cellular Inhibitor of Virus Infectivity. J. Virol.
77: 11398-11407
[Abstract]
[Full Text]